Meeting of the National Vaccine Advisory Committee, 20117 [E7-7682]

Download as PDF Federal Register / Vol. 72, No. 77 / Monday, April 23, 2007 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Vaccine Advisory Committee Department of Health and Human Services, Office of the Secretary. ACTION: Notice. jlentini on PROD1PC65 with NOTICES AGENCY: SUMMARY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (DHHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a meeting by conference call. The meeting is open to the public. DATES: The meeting will be held on May 11, 2007, from 1 p.m. to 2:30 p.m. ADDRESSES: This meeting will be held by conference call. FOR FURTHER INFORMATION CONTACT: Ms. Emma English, Program Analyst, National Vaccine Program Office, Department of Health and Human Services, Room 443–H Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201; (202) 690–5566, nvpo@hhs.gov. SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public Service Act (42 U.S.C. Section 300aa–1), the Secretary of Health and Human Services was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. The NVAC was established to provide advice and make recommendations to the Assistant Secretary for Health, as the Director of the National Vaccine Program, on matters related to the program’s responsibilities. This is a special meeting of the NVAC. Discussions will surround a draft document titled ‘‘The Promise and Challenge of Adolescent Immunization,’’ prepared at the request of the Assistant Secretary for Health by the Committee’s Adolescent Immunization Working Group. The Committee will review the draft document and the Committee will vote to either endorse the document as an official NVAC report or request that further revisions be made to the document by the Working Group. A copy of this draft document can be found on the World Wide Web (https:// www.hhs.gov/nvpo) or by contacting the contact person identified above. For this special meeting, remote participation will be made available via a toll-free call-in phone number. This call-in number can be obtained from the VerDate Aug<31>2005 19:17 Apr 20, 2007 Jkt 211001 contact person identified above and will be operator assisted to provide members of the public the opportunity to provide comments to the Committees. Members of the public will have the opportunity to provide comments at the meeting. Public comment will be limited to five minutes per speaker. Any members of the public who wish to have printed written comment made available to the Committee members should submit materials to the Executive Secretary, NVAC, through the contact person listed above prior to close of business May 7, 2007. Any written materials submitted by the public that are to be discussed by the Committee will be made available via the World Wide Web (https:// www.hhs.gov/nvpo) prior to the meeting. Dated: April 17, 2007. Raymond Strikas, Medical Advisor, National Vaccine Program Office. [FR Doc. E7–7682 Filed 4–20–07; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Assistant Secretary for Preparedness and Response; HHS Public Health Emergency Medical Countermeasures Enterprise Implementation Plan for Chemical, Biological, Radiological and Nuclear Threats Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services ACTION: Notice. AGENCY: SUMMARY: The United States faces serious public health threats from the deliberate use of weapons of mass destruction (WMD)—chemical, biological, radiological, or nuclear (CBRN)—by hostile States or terrorists, and from naturally emerging infectious diseases that have a potential to cause illness on a scale that could adversely impact national security. Effective strategies to prevent, mitigate, and treat the consequences of CBRN threats is an integral component of our national security strategy. To that end, the United States must be able to rapidly develop, stockpile, and deploy effective medical countermeasures to protect the American people. The HHS Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) has taken a holistic, end-to-end approach that considers multiple aspects of the medical countermeasures mission including research, PO 00000 Frm 00013 Fmt 4703 Sfmt 4703 20117 development, acquisition, storage, maintenance, deployment, and guidance for utilization. Phase one of this approach established the HHS PHEMCE Strategy for Chemical, Biological, Radiological, and Nuclear Threats (HHS PHEMCE Strategy). The HHS PHEMCE Strategy, published in the Federal Register on March 20, 2007, described a framework of strategic policy goals and objectives for identifying medical countermeasure requirements and establishing priorities for medical countermeasure evaluation, development and acquisition. These strategic policy goals and objectives were used to establish the Four Pillars upon which this HHS Public Health Emergency Medical Countermeasures Enterprise Implementation Plan (HHS PHEMCE Implementation Plan) is based. The HHS PHEMCE Implementation Plan considers the full spectrum of medical countermeasuresrelated activities, including research, development, acquisition, storage/ maintenance, deployment, and utilization. The HHS PHEMCE Implementation Plan is consistent with the President’s Biodefense for the 21st Century and is aligned with the National Strategy for Medical Countermeasures against Weapons of Mass Destruction. This notice is effective as of April 16, 2007. DATES: Dr. Susan Coller, Policy Analyst, Office of Public Health Emergency Medical Countermeasures, Office of the Assistant Secretary for Preparedness and Response at 330 Independence Ave., SW., Room G640, Washington, DC 20201 or by phone 202–260–1200. FOR FURTHER INFORMATION CONTACT: HHS PHEMCE Approach to Medical Countermeasures The United States faces serious public health threats from the deliberate use of chemical, biological, radiological, or nuclear (CBRN) threat agents by hostile states or terrorists, and from naturally emerging infectious diseases that have the potential to cause illness on a scale that would impact national security. Within the Federal government, the mission of the Department of Health and Human Services (HHS) is to protect the civilian population by providing leadership in research, development, acquisition, deployment, and guidance for effective use of medical countermeasures for mitigation of CBRN events. This key role was identified in the National Strategy to Combat Weapons of Mass E:\FR\FM\23APN1.SGM 23APN1

Agencies

DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 72, Number 77 (Monday, April 23, 2007)]
[Notices]
[Page 20117]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-7682]



[[Page 20117]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: Department of Health and Human Services, Office of the 
Secretary.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (DHHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) will hold a meeting 
by conference call. The meeting is open to the public.

DATES: The meeting will be held on May 11, 2007, from 1 p.m. to 2:30 
p.m.

ADDRESSES: This meeting will be held by conference call.

FOR FURTHER INFORMATION CONTACT: Ms. Emma English, Program Analyst, 
National Vaccine Program Office, Department of Health and Human 
Services, Room 443-H Hubert H. Humphrey Building, 200 Independence 
Avenue, SW., Washington, DC 20201; (202) 690-5566, nvpo@hhs.gov.

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Service Act (42 U.S.C. Section 300aa-1), the Secretary of Health and 
Human Services was mandated to establish the National Vaccine Program 
to achieve optimal prevention of human infectious diseases through 
immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The NVAC was established to provide advice and 
make recommendations to the Assistant Secretary for Health, as the 
Director of the National Vaccine Program, on matters related to the 
program's responsibilities.
    This is a special meeting of the NVAC. Discussions will surround a 
draft document titled ``The Promise and Challenge of Adolescent 
Immunization,'' prepared at the request of the Assistant Secretary for 
Health by the Committee's Adolescent Immunization Working Group. The 
Committee will review the draft document and the Committee will vote to 
either endorse the document as an official NVAC report or request that 
further revisions be made to the document by the Working Group. A copy 
of this draft document can be found on the World Wide Web (https://
www.hhs.gov/nvpo) or by contacting the contact person identified above.
    For this special meeting, remote participation will be made 
available via a toll-free call-in phone number. This call-in number can 
be obtained from the contact person identified above and will be 
operator assisted to provide members of the public the opportunity to 
provide comments to the Committees. Members of the public will have the 
opportunity to provide comments at the meeting. Public comment will be 
limited to five minutes per speaker. Any members of the public who wish 
to have printed written comment made available to the Committee members 
should submit materials to the Executive Secretary, NVAC, through the 
contact person listed above prior to close of business May 7, 2007. Any 
written materials submitted by the public that are to be discussed by 
the Committee will be made available via the World Wide Web (https://
www.hhs.gov/nvpo) prior to the meeting.

    Dated: April 17, 2007.
Raymond Strikas,
Medical Advisor, National Vaccine Program Office.
[FR Doc. E7-7682 Filed 4-20-07; 8:45 am]
BILLING CODE 4150-44-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.